2Meriggioli MN,Sanders DB.Autoimmune myasthenia gravis:emerging clinical and biological heterogeneity[J].Lancet Neurol,2009,8(5):475-490.
3Skeie GO,Apostolski S,Evoli A,et al.Guidelines for the treatment of autoimmune neuromuscular transmission disorders[J].Eur J Neurol,2006,13(7):691-699.
4Skeie GO,Apostolski S,Evoli A,et al.Guidelines for treatment of autoimmune neuromuscular transmission disorders[J].Eur J Neurol,2010 Apr 12.
5Sugawara M,Wada C,Okawa S,et al.Long-term follow up of thymus in patients with myasthenia gravis[J].J Neuroimmunol,2010,221(1-2):121-124.
6Okumura M,Ohta M,Tateyama H,at al.The World Health Organization histologic classification system reflects the oncologic behavior of thymomas clinical study of 273 patients[J].Cancer,2002,94:624-632.
7Prokakis C.Kolelsis E.Salakou S,et al.Modified maximal thymectomy for myasthenia gravis:Effect of maximal resection on late neurologic outcome and predictors of disease remission[J].Ann Thorac Surg,2009,88(5):1638-1645.
8Skeie GO,Apostolski S.Evoli A,et al.Guidelines for treatment of autoimmune neuromuscular transmission disorders[J].European Journal of Neurology,2010,17(7):893-902.
9Palmisani MT,Evoli A.Batoechi AP,et al.Myasthenia gravis associated with thymoma[J].Eur Neurol,1993,34:78.
